Skip to main content
. 2022 Jul 19;13:948599. doi: 10.3389/fneur.2022.948599

Table 2.

Comparison between groups on WAIS-IV and WMS-IV.

Cognitive function Baseline Endpoint
Probiotic Placebo Z P Probiotic Placebo Z P
WAIS-IV
VCI 91.37 (15.41) 90.97 (15.61) −0.065 0.948 92.57 (15.03) 92.14 (15.23) −0.047 0.962
PRI 84.11 (16.25) 85.03 (16.25) −0.27 0.787 85.46 (15.83) 85.29 (16.22) −0.024 0.981
PSI 84.60 (15.77) 82.17 (15.85) −0.565 0.572 93.77 (15.83) 83.29 (15.91) −2.716 0.007
WMI 84.26 (15.13) 85.80 (16.67) −0.406 0.685 95.23 (15.48) 86.57 (17.08) −2.105 0.035
FSIQ 86.09 (10.30) 85.99 (10.71) −0.012 0.991 91.76 (9.21) 86.82 (10.54) −1.915 0.049
WMS-IV
AMI 83.03 (16.19) 83.29 (16.07) −0.194 0.846 92.91 (17.19) 83.57 (16.01) −2.165 0.03
VMI 87.31 (15.56) 85.20 (18.05) −0.6 0.549 95.54 (15.36) 87.17 (18.25) −2.016 0.044
VWMI 82.80 (17.34) 82.94 (17.30) −0.1 0.92 85.09 (18.04) 83.49 (17.69) −0.388 0.698
IMI 85.14 (15.14) 84.66 (15.73) −0.147 0.883 94.11 (16.15) 86.17 (15.20) −2.454 0.014
DMI 85.11 (15.52) 84.11 (15.05) −0.076 0.939 94.11 (16.53) 86.14 (15.71) −2.194 0.028

The WAIS-IV and WMS-IV scores are presented in corresponding age-adjusted scaled scores (index scores M = 100, SD = 15). “Z” indicates Mann Whitney U test. Bonferroni correction was applied to determine statistical significance.